Researchers have developed a machine learning model called DreaMS, which significantly accelerates the analysis of previously unknown molecules. The study is published in Nature Biotechnology.

Rokeby brings a distinctive perspective to this exploration through his work as director of the University of Toronto’s BMO ...

Nucleome Therapeutics (‘Nucleome’ or ‘the Company’), a biotechnology company harnessing the power of non-coding human genetics to discover first-in-class antibody treatments for inflammatory diseases, ...

UK biotech Nucleome Therapeutics has appointed Bhavna Hunjan as chief business officer, a move that strengthens its ...

This year's winner of the Neuron Award for young promising scientists, Dr. Tomáš Pluskal from IOCB Prague, together with his student Roman Bushuiev ...

Blood vessels are like big-city highways; full of curves, branches, merges, and congestion. Yet for years, lab models ...

Manufacturing CAR T cells in the laboratory is expensive and time-consuming. An in vivo approach could get the powerful ...

The human organism is far too complex and unpredictable to program like a computer and optimize for longevity.

With YouTuber subscribers of over 137K, Cogley, also a mechatronics engineer, has a special interest in animatronics.

In a world increasingly driven by technology, the fusion of human physiology with robotics is at the forefront of innovative ...

According to Miguel Angel Moratinos, spirituality is more required for people today than ever, because it is a part of human nature ...